Home »News »Press Release

Beijing United Family Hospital and Clinics Recognized for Excellence

in Commitment to Quality

     First Healthcare Network in Asia Accredited by Joint Commission International

BETHESDA , MARYLAND - December 12, 2005 - Beijing United Family Hospital and Clinics have recently earned accreditation from the Joint Commission International, the worldwide leader in improving the quality of health care.


Beijing United Family Hospital ("Beijing United") is a unique foreign invested international standard hospital in Beijing serving the international community and elite private pay domestic patients. The hospital is a joint venture between Chindex International and the Union Pharmaceutical Company of the Chinese Academy of Medical Sciences. From its conception Beijing United designed its facilities and service offerings to meet stringent international standards. The recent achievement of recognition by the international accreditation organization is a measure of proof that the organization has achieved a level of world class quality and is committed to ongoing quality improvement. The hospital's two affiliated clinics situated in Shunyi at the Pinnacle Plaza and in downtown Beijing at the St. Regis Hotel Complex were also accredited by the Commission.


Beijing United Family Hospital and Clinics is the first integrated health system in Asia to achieve accreditation by the Joint Commission.


The Commission's on-site evaluations of Beijing United Family Hospital and Clinics were concluded in September 2005 and were conducted by a team of international health care experts, including a doctor, nurse and administrator.


"We sought accreditation because we want to provide the best care for our patients," commented Roberta Lipson , Chairman of Beijing United Family Hospital and Clinics and CEO of Chindex International. "Earning accreditation from the Joint Commission International is another step toward excellence."


Rex Hancock , Director of Quality for the hospital and clinics, notes that accreditation is attainable only through collaboration among all organization staff members: "Providing high quality care is a team effort that gives employees a feeling of prestige and patients a feeling of confidence."


Although the Joint Commission is not officially recognized as an accreditation body by the Chinese Government, the Commission's uniform, high standards for patient care and safety are designed to be adaptable to local legal and cultural factors.


"Health care organizations around the world want to create environments that focus on quality, safety and continuous improvement," says Karen Timmons, Chief Executive Officer, Joint Commission International. "Accreditation meets this demand by stimulating continuous, systematic improvements in an organization's performance and the outcomes of patient care. The community should be proud that United Family Hospitals and Clinics has made a commitment to quality and safety."

About Chindex International, Inc.

Chindex is an American healthcare company which owns and operates the only foreign invested and managed international standard hospitals and affiliated ambulatory clinics in the People's Republic of China serving both International and Chinese patients with premium quality and service.


The company also distributes medical equipment the Chinese marketplace, including Hong Kong . It sells medical equipment produced by a number of major multinational companies including Siemens AG as its exclusive distribution partner for the sales and servicing of color doppler ultrasound systems. It also arranges financing packages for the supply of medical equipment to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. It provides healthcare services through the operations of its network of private primary care hospitals and affiliated ambulatory clinics in China . With twenty-four years of experience, over 1,000 employees, and operations in the United States , China and Hong Kong , the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, and .


Some of the information in this press release may contain statements regarding future expectations, plans, prospects for performance of the Company that constitute forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. The Company cannot guarantee future results, levels of activity, performance or achievements. The numbers discussed in this press release also involve risks and uncertainties. The following factors, among others, could cause actual results to differ materially from those described by such statements: our ability to manage our growth and maintain adequate controls, our ability to obtain additional financing, the loss of services of key personnel, general market conditions including inflation or foreign currency fluctuations, our dependence on relationships with suppliers, the timing of our revenues and fluctuations in financial performance, the availability to our customers of third-party financings, product liability claims and product recalls, competition, hiring and retaining qualified sales and service personnel, management of inventory, relations with foreign trade corporations, dependence on sub-distributors and dealers, completion and opening of healthcare facilities, attracting and retaining qualified physicians and other hospital personnel, regulatory compliance, the cost of malpractice, our dependence on our information systems, the economic policies of the Chinese government, the newness and undeveloped nature of the Chinese legal system, the regulation of the conversion of Chinese currency, future epidemics in China such as SARS or Avian Flu, the control over our operation by insiders, continuity of relationships and variability of financial margins with existing suppliers, our liquidity and availability of capital resources to meet cash requirements, including capital expenditures and bid and performance bonds, and those other factors contained in the section titled "Risk Factors" as set forth in the Company's Registration Statement on Form S-3 (File No. 333-114996) filed with the Securities and Exchange Commission, as well as other documents that may be filed by the Company from time to time with the Securities and Exchange Commission. The forward-looking statements and numbers contained herein represent the judgment of the Company, as of the date of this press release, and the Company disclaims any intent or obligation to update such forward-looking statements to reflect any change in the Company's expectations with regard thereto or any change in events, conditions, or circumstances on which such statements are based.


Copyright © 2002 Chindex International, Inc. All Rights Reserved